Skip to main content

Table 3 Anti-hyperlipidemic activity for EZ heads on Propylthiouracil induced hyperlipidemic rats

From: Characterization and interactions between piperine and ezetimibe in their Anti-hyperlipidemic efficacy using Biopharmaceutics and Pharmacokinetics

Group

TG (mmol/L)

TC (mmol/L)

LDL (mmol/L)

HDL (mmol/L)

VLDL (mmol/L)

I

95.64 ± 2.63

172.54 ± 2.69

93.46 ± 1.95

83.26 ± 2.39

18.34 ± 0.65

II

236.45 ± 2.84

269.85 ± 3.45

215.64 ± 2.64

20.43 ± 1.36

52.34 ± 0.42

III

139.85 ± 1.95

213.46 ± 2.75

149.68 ± 2.13

36.59 ± 2.31

31.24 ± 0.31

IV

126.95 ± 2.64

195.86 ± 1.03

123.46 ± 1.06

40.24 ± 0.64

26.59 ± 0.25

V

118.25 ± 2.13

169.84 ± 1.26

112.43 ± 1.05

52.36 ± 0.98

24.53 ± 0.13

VI

109.64 ± 1.34

156.34 ± 1.05

106.58 ± 1.27

59.84 ± 0.46

20.64 ± 0.32

VII

101.23 ± 1.26

142.35 ± 1.34

82.34 ± 1.05

67.21 ± 0.52

18.64 ± 0.16